Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modulation of TIM receptor activity in combination with cytoreductive therapy

Modulation of TIM receptor activity in combination with cytoreductive therapy

US Patent 8709412 · Granted Apr 29, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of assessing the efficacy of a test agent for modulating programmed death2025
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor 2025
Methods for upregulating immune responses using combinations of anti-RGMb and an2024
KIR3DL3 as an HHLA2 receptor, anti-HHLA2 antibodies, and uses thereof2024
Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof2024
Antibody molecules to PD-1 and uses thereof2023
Methods and compositions comprising a nitrite-reductase promoter for treatment o2023
Compositions and methods for identification, assessment, prevention, and treatme2023
Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, metho2022
Agents that modulate RGMb-neogenin-BMP signaling and methods of use thereof2022
Agents that modulate RGMb-neogenin-BMP signaling and methods of use thereof2022
Agents that modulate RGMb-neogenin-BMP signaling and methods of use thereof2022